Medical Devices Segment Capabilities 60% Companies
Total Page:16
File Type:pdf, Size:1020Kb
Engineering Service Providers – Capabilities Study July 2018 1 1 Source : DRAUP 1 Ranking Modular Framework and Methodology Rating Parameters Weightages Financials 25% Total Employees 100% Project Headcount 25% Design & Development 25% Testing & Automation 25% Sustenance & Maintenance 25% The list of total 8 companies Regulatory Compliances & Support Services 25% were analysed on all mentioned parameters and Client Base 25% weightage has been given for Client partnership 60% Partnership Maturity 40% each of them to arrive at the list of Top 8 Service Providers Capabilities 25% catering to Medical Devices Segment Capabilities 60% companies. Imaging Diagnostics 10% Non-Imaging Diagnostics 10% Surgical Devices 10% Monitoring Devices 10% Prosthetics 10% Other Therapeutic Devices 10% Emerging Technologies 40% 2 Note – Framework and Modular Created by DRAUP and updated in July 2018 Source : DRAUP 2 Service Providers Ranking across Medical Devices Outsourcing Landscape 1 HCL 2 TCS 3 Altran 4 Wipro Financials 5 4 3 2 Project Headcount 4 3 2 2 Client Base 5 4 5 3 Capabilities 3 4 3 2 5 Quest Global 6 Infosys 7 Global Logic 8 Tech Mahindra Financials 1 1 2 1 Project Headcount 1 1 2 1 Client Base 4 3 2 3 Capabilities 3 3 3 2 Lowest rating 1 2 3 4 5 Highest rating 3 Note : The above analysis is based on the DRAUP’s proprietary engineering and talent database and insights from industry stakeholders, updated as on July, 2018 Source : DRAUP 3 Wipro – Financial Overview • In 2018, the company began building software to help with the General Data Protection Regulation (GDPR) in Europe. • Wipro was opening manufacturing locations in Andhra Pradesh and Guangzhou on April 2018. 1945 Bangalore, India $ 8.4 billion ~ 162,553 Year of Establishment Company Headquarters Revenue (FY’17) Employees (FY’18) Revenue Growth (in Billion) – 5.82% Revenue by Geography (FY 2017) (for 5 years) Revenue CAGR Business Segments (5 Yrs) America 8.5 8.4 7.9 53% 97% 7.2 IT Services 6.7 Europe 26% IT Products 3% APAC and OEM 11% India and Middle East 10% Revenue % 2013 2014 2015 2016 2017 4 Note – DRAUP data curated from Wipro financial reports published annually and updated in July, 2018 Source : DRAUP 4 Wipro – Medical Dashboard Product Engineering HC Split 60% 15% 15% 10% Design & Development Testing & Automation Sustenance & Maintenance Regulatory Compliance & Support Services ~ $40 – 60 Mn Revenue (FY’17) Key Clients ~ 650 – 750 Head Count (FY’17) Key Developments • Usage of non-invasive wearable sensors, mobility, cloud-based analytics and evidence-based decision support systems. • Claims Administration, Medicaid Medical Management,Health Risk Assessment (Clinical and Behavioral) HRA, 44% complex case management, Medicaid Care Management platform for integrated behavioral-clinical programs. Onsite Percentage • Hospital Information System to automate clinical, electronic medical records (EMR), administrative and inventory functions. 5 Note – DRAUP data curated from Wipro financial reports published annually and updated in July, 2018 Source : DRAUP 5 Wipro – Key Medical Capabilities (1/2) Imaging Diagnostics Non-Imaging Diagnostics • Development of codes for computer- • Cardiology, Neurology, Oncology, based tool used for testing the pulse rate of the patient during invasive and Vascular, Molecular imaging and non-invasive breathe-down. Interventional Imaging systems. • Development of advanced touch • AW streamlines post-processing by screen maternal fetal monitor to monitor the maternal and fetal vital bringing together all imaging signs to help assess maternal and techniques, AW boosts your fetal well-being. • Monitor the vital signs like maternal productivity across all modalities blood pressure (NIBP), pulse oximetry such as CT, MR, PET, SPECT, (MSpO2), maternal heart rate Interventional, and presents a (MHR/MECG), and fetal heart rate (FHR/FECG). consistent user interface for all • The ABL90 FLEX analyzer combines clinical applications. the high measuring accuracy with the • New product design in the field of ease of use. Designed specifically for point-of-care testing, the analyzer Patient handling and Electronic measures 17 parameters, including packaging of electronic modules for blood gas, electrolytes, metabolites MRI Scanners. and CO-oximetry from just 65?L of whole blood. Mixing and measurement of the blood sample is done automatically. 6 Note – DRAUP data curated from Wipro financial reports published annually and updated in July, 2018 Source : DRAUP 6 Wipro – Key Medical Capabilities (2/2) Monitoring Devices Other Therapeutic Devices & Surgical Devices • Development of AERO Remote Control, a mobile device, generally containing an embedded blood • Cardiac Implant Monitoring System, glucose meter, capable of EMRGateway, Cardiac Event communicating with a CGM sensor Monitoring System and Care Ports patch connected through Bluetooth development. with he Remote Control Device. It is a Class-C medical device project • Development of Mobile Application designed for the patients suffering for real time monitoring of ECG from diabetic s type-1 and type -2. Signal. • Implementation of MedibusX in • Medicine transfusion (Value Delta s last release to make it engineered infusion pump), IGS for compatible with the available surgeries Ventilators, Anesthetic Devices and other MedibusX products in the market. 7 Note – DRAUP data curated from Wipro financial reports published annually and updated in July, 2018 Source : DRAUP 7 Altran – Financial Overview Altran Technologies is active in innovation and advanced engineering consulting. The company covers the entire project life-cycle, from the planning stages (technological monitoring, technical feasibility studies, strategy planning, etc.) to final realization (design, implementation, testing, etc.).. 1982 Paris, France $2.73 Billion ~2,00,364 Year of Establishment Company Headquarters Revenue (FY’17) Employees (FY’17) Revenue Growth Revenue by Geography (FY 2017) Business Segments (in $Billion) - (for 5 years ) (8.78) % Energy, Industrials and Life 2.73 24% Revenue CAGR 2.53 France Sciences (5 Yrs) 2.32 2.1 40% Automotive 23% 1.95 Northern Europe 33% Aerospace, Defense and Rail 23% Southern Europe Medical, Hi-tech and Media 18% 20% Finance and Public Sector 12% Rest of others 7% Revenue % 2013 2014 2015 2016 2017 8 Note – DRAUP data curated from Altran financial reports published annually and updated in July, 2018 Source : DRAUP 8 Altran – Medical Dashboard Product Engineering HC Split 60% 21% 9% 10% Design & Development Testing & Automation Sustenance & Maintenance Regulatory Compliance & Support Services ~ $70 – 100 Mn Revenue (FY’17) Key Clients ~ 800 – 900 Head Count (FY’17) Key Developments • DISDEO: Developing an intelligent medical device enabling a better observance of medical treatments • Smart Patient Adherence, a secure, end-to-end user-centric solution, connecting real-time connected objects surrounding the patient (pillboxes, blisters, etc.) and providing a communication platform between patients, 90% doctors and Life Sciences companies to monitor and improve patient adherence. Onsite Percentage • Cloud-Based Portal for Mobile Imaging Device • Population Care Management Architecture 9 Note – DRAUP data curated from Altran financial reports published annually and updated in July, 2018 Source : DRAUP 9 Altran – Key Medical Capabilities (1/2) Imaging Diagnostics Non-Imaging Diagnostics • XylemDx offers instant personalised • Medic@ aims at developing testing at the doctor’s surgery or services for high performance pharmacy for signs ranging from the medical images treatment for the latest strain of the flu virus to specific biomarkers for genetic heart preparation, supervision or conditions. simulation of surgery. • The XylemDx technology turns a • Integrated into tools for medical sheet of paper into any one of a imaging. variety of different diagnostic tests, • Exploited based on images and each of which can be produced on the same fabrication device. integrated with shared medical • Each piece of paper can be configured imaging platforms. with a bespoke set of test modules – • Implementation of the product as a for example, electronic, thermal, part of virtual laboratories. fluidic, optical or biological reagent modules – before being folded concertina-style into the traditional test cartridge shape. 10 Note – DRAUP data curated from Altran financial reports published annually and updated in July, 2018 Source : DRAUP 10 Altran – Key Medical Capabilities (2/2) Other Therapeutic Devices Surgical Devices & Monitoring Devices • Vena platform, that supports a set of standards that have been selected by the Continua Health Alliance to guarantee compatibility • The MEDIC@ program aims at between personal health devices. proposing a system of augmented • As well as providing Bluetooth, and reality and simulation with clinical USB connectivity, the single chip added value, improving the quality Vena platform can be used as the of surgery in an operating block, in core of a complete device providing particular laparoscopic surgery like user interface and sensor ablation of liver tumors. processing, or as an addition to an • The various monitoring devices are existing device. • Picado • VueForge® Connect: full featured • Disdeo IoT Platform for various purposes. • VENA 11 Note – DRAUP data curated from Altran financial reports published annually and updated in July, 2018 Source : DRAUP 11 Infosys – Financial Overview Infosys provides software development, maintenance and independent validation services to companies